2025-2031 Global Bacille Calmette-Guerin Vaccine Industry Research & Trends Analysis Report- YH Research

Home > Reports >Pharma & Healthcare > 2025-2031 Global Bacille Calmette-Guerin Vaccine Industry Research & Trends Analysis Report

2025-2031 Global Bacille Calmette-Guerin Vaccine Industry Research & Trends Analysis Report

Publication Date: 2025-11-19
Report Id: 2807789
Industry: Pharma & Healthcare
Report Page: 137
Chart: 135

PDF Download

Publication Date: 2025-11-19
Report Id: 2807789
Industry: Pharma & Healthcare
Report Page: 137
Chart: 135

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Bacille Calmette-Guerin Vaccine Definition
1.2 Global Bacille Calmette-Guerin Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
1.2.2 By Sales Volume, Global Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
1.2.3 Global Bacille Calmette-Guerin Vaccine Price Trend, 2020-2031
1.3 China Bacille Calmette-Guerin Vaccine Market Size and Forecast
1.3.1 By Revenue, China Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
1.3.2 By Sales Volume, China Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
1.3.3 China Bacille Calmette-Guerin Vaccine Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Bacille Calmette-Guerin Vaccine Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Bacille Calmette-Guerin Vaccine Share in Global Market, 2020-2031
1.4.3 Bacille Calmette-Guerin Vaccine Market Size: China VS Global, 2020-2031
1.5 Bacille Calmette-Guerin Vaccine Market Dynamics
1.5.1 Bacille Calmette-Guerin Vaccine Market Drivers
1.5.2 Bacille Calmette-Guerin Vaccine Market Restraints
1.5.3 Bacille Calmette-Guerin Vaccine Industry Trends
1.5.4 Bacille Calmette-Guerin Vaccine Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Company, 2020-2025
2.2 Global Bacille Calmette-Guerin Vaccine Sales Volume by Company, 2020-2025
2.3 Global Bacille Calmette-Guerin Vaccine Price by Company, 2020-2025
2.4 Global Bacille Calmette-Guerin Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Bacille Calmette-Guerin Vaccine Concentration Ratio
2.6 Global Bacille Calmette-Guerin Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Bacille Calmette-Guerin Vaccine Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Bacille Calmette-Guerin Vaccine Revenue by Company, 2020-2025
3.2 China Bacille Calmette-Guerin Vaccine Sales Volume by Company, 2020-2025
3.3 China Bacille Calmette-Guerin Vaccine Bacille Calmette-Guerin Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Bacille Calmette-Guerin Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Bacille Calmette-Guerin Vaccine Domestic VS Export
3.6 China Market, Bacille Calmette-Guerin Vaccine Import & Export
3.6.1 China Market, Bacille Calmette-Guerin Vaccine Import & Export, 2020-2031
3.6.2 China Bacille Calmette-Guerin Vaccine Import & Export Trends
3.6.3 Main Sources of China Bacille Calmette-Guerin Vaccine Import
3.6.4 Export Destination of China Bacille Calmette-Guerin Vaccine

4 Bacille Calmette-Guerin Vaccine Production by Region
4.1 Global Bacille Calmette-Guerin Vaccine Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Bacille Calmette-Guerin Vaccine Manufacturers
4.3 Global Major Manufacturers, Bacille Calmette-Guerin Vaccine Capacity Expansion and Future Plans
4.4 Global Bacille Calmette-Guerin Vaccine Capacity by Region
4.5 Global Bacille Calmette-Guerin Vaccine Production by Region
4.5.1 Global Bacille Calmette-Guerin Vaccine Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Bacille Calmette-Guerin Vaccine Production by Region, 2020-2025
4.5.3 Global Bacille Calmette-Guerin Vaccine Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Bacille Calmette-Guerin Vaccine Industry Chain
5.2 Bacille Calmette-Guerin Vaccine Upstream Analysis
5.2.1 Bacille Calmette-Guerin Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Bacille Calmette-Guerin Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Bacille Calmette-Guerin Vaccine Production Mode
5.6 Bacille Calmette-Guerin Vaccine Procurement Model
5.7 Bacille Calmette-Guerin Vaccine Industry Sales Model and Sales Channels
5.7.1 Bacille Calmette-Guerin Vaccine Sales Model
5.7.2 Bacille Calmette-Guerin Vaccine Typical Distributors

6 Sights by Product Type
6.1 Bacille Calmette-Guerin Vaccine Classification
6.1.1 Immune Vaccine
6.1.2 Therapy Vaccine
6.2 by Type, Global Bacille Calmette-Guerin Vaccine Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Bacille Calmette-Guerin Vaccine Revenue, 2020-2031
6.4 by Type, Global Bacille Calmette-Guerin Vaccine Sales Volume, 2020-2031
6.5 by Type, Global Bacille Calmette-Guerin Vaccine Price, 2020-2031

7 Sights by Application
7.1 Bacille Calmette-Guerin Vaccine Segment by Application
7.1.1 Self-Procurement
7.1.2 UNICEF
7.1.3 Other
7.2 by Application, Global Bacille Calmette-Guerin Vaccine Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Bacille Calmette-Guerin Vaccine Revenue, 2020-2031
7.4 by Application, Global Bacille Calmette-Guerin Vaccine Sales Volume, 2020-2031
7.5 by Application, Global Bacille Calmette-Guerin Vaccine Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Bacille Calmette-Guerin Vaccine Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Bacille Calmette-Guerin Vaccine Revenue, 2020-2031
8.3 By Region, Global Bacille Calmette-Guerin Vaccine Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Bacille Calmette-Guerin Vaccine Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Bacille Calmette-Guerin Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Bacille Calmette-Guerin Vaccine Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Bacille Calmette-Guerin Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Bacille Calmette-Guerin Vaccine Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Bacille Calmette-Guerin Vaccine Market Size Market Share
8.7 South America
8.7.1 South AmericaBacille Calmette-Guerin Vaccine Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Bacille Calmette-Guerin Vaccine Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Bacille Calmette-Guerin Vaccine Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Bacille Calmette-Guerin Vaccine Revenue, 2020-2031
9.3 By Country, Global Bacille Calmette-Guerin Vaccine Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
9.4.2 By Company, United States Bacille Calmette-Guerin Vaccine Sales Volume Market Share, 2024
9.4.3 by Type, United States Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
9.5.2 By Company, Europe Bacille Calmette-Guerin Vaccine Sales Volume Market Share, 2024
9.5.3 by Type, Europe Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
9.6.2 By Company, China Bacille Calmette-Guerin Vaccine Sales Volume Market Share, 2024
9.6.3 by Type, China Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
9.7.2 By Company, Japan Bacille Calmette-Guerin Vaccine Market Share, 2024
9.7.3 by Type, Japan Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
9.8.2 By Company, South Korea Bacille Calmette-Guerin Vaccine Market Share, 2024
9.8.3 by Type, South Korea Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Bacille Calmette-Guerin Vaccine Market Share, 2024
9.9.3 by Type, Southeast Asia Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
9.10.2 By Company, India Bacille Calmette-Guerin Vaccine Market Share, 2024
9.10.3 by Type, India Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Bacille Calmette-Guerin Vaccine Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Bacille Calmette-Guerin Vaccine Market Share, 2024
9.11.3 by Type, Middle East & Africa Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Bacille Calmette-Guerin Vaccine Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.1.2 Merck Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.1.3 Merck Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 Japan BCG Lab
10.2.1 Japan BCG Lab Company Information, Head Office, Market Area, and Industry Position
10.2.2 Japan BCG Lab Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.2.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Japan BCG Lab Company Profile and Main Business
10.2.5 Japan BCG Lab Recent Developments
10.3 Serum Institute of India
10.3.1 Serum Institute of India Company Information, Head Office, Market Area, and Industry Position
10.3.2 Serum Institute of India Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.3.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Serum Institute of India Company Profile and Main Business
10.3.5 Serum Institute of India Recent Developments
10.4 AJ Vaccines
10.4.1 AJ Vaccines Company Information, Head Office, Market Area, and Industry Position
10.4.2 AJ Vaccines Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.4.3 AJ Vaccines Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.4.4 AJ Vaccines Company Profile and Main Business
10.4.5 AJ Vaccines Recent Developments
10.5 BioFarma
10.5.1 BioFarma Company Information, Head Office, Market Area, and Industry Position
10.5.2 BioFarma Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.5.3 BioFarma Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.5.4 BioFarma Company Profile and Main Business
10.5.5 BioFarma Recent Developments
10.6 GreenSignal Bio Pharma
10.6.1 GreenSignal Bio Pharma Company Information, Head Office, Market Area, and Industry Position
10.6.2 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.6.3 GreenSignal Bio Pharma Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.6.4 GreenSignal Bio Pharma Company Profile and Main Business
10.6.5 GreenSignal Bio Pharma Recent Developments
10.7 China National Biotec
10.7.1 China National Biotec Company Information, Head Office, Market Area, and Industry Position
10.7.2 China National Biotec Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.7.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.7.4 China National Biotec Company Profile and Main Business
10.7.5 China National Biotec Recent Developments
10.8 Biomed Lublin
10.8.1 Biomed Lublin Company Information, Head Office, Market Area, and Industry Position
10.8.2 Biomed Lublin Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.8.3 Biomed Lublin Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Biomed Lublin Company Profile and Main Business
10.8.5 Biomed Lublin Recent Developments
10.9 Taj Pharmaceuticals
10.9.1 Taj Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.9.2 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.9.3 Taj Pharmaceuticals Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Taj Pharmaceuticals Company Profile and Main Business
10.9.5 Taj Pharmaceuticals Recent Developments
10.10 Ataulpho de Paiva
10.10.1 Ataulpho de Paiva Company Information, Head Office, Market Area, and Industry Position
10.10.2 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.10.3 Ataulpho de Paiva Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Ataulpho de Paiva Company Profile and Main Business
10.10.5 Ataulpho de Paiva Recent Developments
10.11 IVAC – Institute of Vaccines and Medical Biologicals
10.11.1 IVAC – Institute of Vaccines and Medical Biologicals Company Information, Head Office, Market Area, and Industry Position
10.11.2 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.11.3 IVAC – Institute of Vaccines and Medical Biologicals Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.11.4 IVAC – Institute of Vaccines and Medical Biologicals Company Profile and Main Business
10.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments
10.12 Queen Saovabha Mem. Inst
10.12.1 Queen Saovabha Mem. Inst Company Information, Head Office, Market Area, and Industry Position
10.12.2 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.12.3 Queen Saovabha Mem. Inst Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.12.4 Queen Saovabha Mem. Inst Company Profile and Main Business
10.12.5 Queen Saovabha Mem. Inst Recent Developments
10.13 Microgen
10.13.1 Microgen Company Information, Head Office, Market Area, and Industry Position
10.13.2 Microgen Bacille Calmette-Guerin Vaccine Models, Specifications, and Application
10.13.3 Microgen Bacille Calmette-Guerin Vaccine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.13.4 Microgen Company Profile and Main Business
10.13.5 Microgen Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Bacille Calmette-Guerin Vaccine should grow from US$ 85.5 million in 2024 to US$ 104 million by 2031, with a CAGR of 2.9% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Bacille Calmette-Guerin Vaccine

According to YH Research, the global market for Bacille Calmette-Guerin Vaccine should grow from US$ 85.5 million in 2024 to US$ 104 million by 2031, with a CAGR of 2.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The Bacille Calmette-Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). Developed from a strain of weakened Mycobacterium bovis, the BCG vaccine is commonly administered to infants and children in countries where tuberculosis is prevalent. While it does not provide complete immunity, it significantly reduces the risk of severe forms of TB, such as TB meningitis and miliary tuberculosis in young children. BCG is also being researched for potential applications in treating bladder cancer and boosting immune responses in certain conditions.

The primary drivers of the Bacille Calmette-Guérin (BCG) vaccine market is the continued high prevalence of tuberculosis (TB) in many parts of the world, particularly in Asia and Africa. Increased awareness and government initiatives to control and eradicate TB contribute to demand for the vaccine. Additionally, ongoing research on the potential use of the BCG vaccine in treating other diseases, such as bladder cancer and potentially as a non-specific immune booster, is also bolstering its market demand.

A major challenge in the BCG vaccine market is supply constraints due to the limited number of manufacturers, as production requires specialized facilities and quality control measures. Additionally, the vaccine's effectiveness varies by region and is less protective in adults than in children, which affects its perception and demand in some areas. Furthermore, stringent regulatory standards and the relatively long time required for production can limit supply, especially during times of increased demand or global health crises. Asia-Pacific is the largest consumption place, with a consumption market share nearly 46% in 2023. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 36%. Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, etc. are the leaders of the industry.

This report aims to provide a comprehensive study of the global market for Bacille Calmette-Guerin Vaccine.
Report Highlights:
(1) Global Bacille Calmette-Guerin Vaccine market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Bacille Calmette-Guerin Vaccine market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Bacille Calmette-Guerin Vaccine market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Bacille Calmette-Guerin Vaccine segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Bacille Calmette-Guerin Vaccine segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Bacille Calmette-Guerin Vaccine, capacity, production and trends.

(7) Bacille Calmette-Guerin Vaccine industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Immune Vaccine
Therapy Vaccine

Market segment by Application, can be divided into
Self-Procurement
UNICEF
Other

Market segment by players, this report covers
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen